KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Payables (2020 - 2025)

Oscar Health (OSCR) has disclosed Payables for 6 consecutive years, with $649.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables rose 50.25% year-over-year to $649.7 million, compared with a TTM value of $649.7 million through Dec 2025, up 50.25%, and an annual FY2025 reading of $649.7 million, up 50.25% over the prior year.
  • Payables was $649.7 million for Q4 2025 at Oscar Health, up from $556.7 million in the prior quarter.
  • Across five years, Payables topped out at $649.7 million in Q4 2025 and bottomed at $121.0 million in Q1 2021.
  • Average Payables over 5 years is $332.2 million, with a median of $285.6 million recorded in 2022.
  • The sharpest move saw Payables decreased 8.22% in 2023, then soared 109.07% in 2025.
  • Year by year, Payables stood at $234.8 million in 2021, then increased by 26.86% to $297.8 million in 2022, then decreased by 8.22% to $273.4 million in 2023, then soared by 58.19% to $432.4 million in 2024, then surged by 50.25% to $649.7 million in 2025.
  • Business Quant data shows Payables for OSCR at $649.7 million in Q4 2025, $556.7 million in Q3 2025, and $583.9 million in Q2 2025.